Pure Boldenone

Description

Boldenone is a synthetic anabolic-androgenic steroid (AAS) derived from testosterone. Chemically, it is known as androsta-1,4-dien-17β-ol-3-one. Its molecular formula is C19H26O2, and its molecular weight is 286.41 g/mol. Its core structure is nearly identical to testosterone. However, the key distinction involves a double bond between carbons 1 and 2. This structural modification significantly alters the compound’s metabolic fate. Consequently, it reduces androgenic potency relative to its anabolic activity. Therefore, the activity of boldenone is mainly anabolic, with a low androgenic potency. Importantly, boldenone itself has never been marketed as a pharmaceutical for humans. Instead, its esterified derivatives are widely used in veterinary medicine.

2. Veterinary Origins and Pharmaceutical Forms

Pharmaceutical companies developed Boldenone primarily for veterinary use. The most common form is boldenone undecylenate. Zoetis markets this compound under the brand name Equipoise. The FDA has approved this product for veterinary applications in horses only. Each milliliter of the injectable solution typically provides 50 mg of boldenone undecylenate in sesame oil. Additionally, benzyl alcohol (3% w/v) serves as a preservative. The undecylenate ester makes the compound long-acting. Its half-life is approximately 14 days. Consequently, this allows for a sustained release profile with a rapid onset of action.

3. Medical Indications in Horses

Veterinarians prescribe Equipoise as an aid for treating debilitated horses. This includes situations where improvement in weight, haircoat, or general physical condition is desired. Debilitation often follows disease. It may also occur after overwork and overexertion. Boldenone improves the general state of debilitated horses. Accordingly, it aids in correcting weight losses and improving appetite. However, it is not a substitute for a well-balanced diet. Optimal results can be expected only with good management and feeding practices. Therefore, veterinarians should consider it only as adjunctive therapy to other specific and supportive treatments.

4. Pharmacological Profile and Mechanism

At a molecular level, boldenone acts similarly to methandrostenolone (Dianabol). However, it has fewer adverse androgenic effects. It increases nitrogen retention and protein synthesis. Furthermore, it stimulates the release of erythropoietin in the kidneys. Although commonly compared to nandrolone, boldenone lacks progesterone receptor interaction. Consequently, it does not produce the associated progestogenic side effects. However, boldenone is a probable human carcinogen. The International Agency for Research on Cancer classified it as such. In animal studies, it has led to disruption of the male reproductive system. It has also caused fertility issues. These include decreased testicle size, reduced sperm count, and reduced sperm mobility.

5. Legal Status and Human Use Warnings

It is crucial to understand that boldenone is not approved for human use. The World Anti-Doping Agency (WADA) lists it as a prohibited substance under S1.1 Anabolic Androgenic Steroids (AAS). Consequently, athletes cannot obtain Therapeutic Use Exemptions for boldenone. There is no therapeutic or medical use for it in humans. Long-term usage of AAS, including boldenone, can have extremely detrimental impacts on the reproductive system. Studies have shown significantly lower levels of testosterone and FSH in AAS users compared to control groups. Therefore, any human use of boldenone outside of a controlled research environment carries serious health risks. We strongly do not recommend it.